Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasendocrinology-diabetes-and-growth

Paeds Vivas · endocrinology-diabetes-and-growth

Delayed puberty and hypogonadism in adolescents — branching viva

Branching viva on delayed puberty: confirming the timing thresholds, splitting the differential with gonadotrophins, separating constitutional delay from permanent congenital hypogonadotropic hypogonadism, recognising Klinefelter and Turner, and delivering pubertal induction with escalating sex steroids over 18 to 24 months.

branching clinical structured oral
On this page & tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
Outpatient clinic: a 14-year-old boy is referred for short stature and absent puberty. He is the shortest in his class, his testes are 3 mL bilaterally, his father 'was always the smallest until age sixteen,' and his bone age lags by two and a half years. The examiner asks: what defines delayed puberty, how do gonadotrophins split the differential, how do you separate constitutional delay from permanent CHH, and what is the role of short-course testosterone — then branches to a second case of a 15-year-old boy with tall stature, small firm testes, gynaecomastia and high gonadotrophins, and asks you to classify, confirm and induce puberty in Klinefelter syndrome.

Opening framework

My framework has four layers. First, the timing — no testicular enlargement (under four millilitres) by 14 in boys or no thelarche by 13 in girls, or a stall of more than two years. Second, the gonadotrophin split — a morning testosterone or oestradiol with FSH and LH divides the differential into a central (hypogonadotropic) and a gonadal (hypergonadotropic) cause. Third, the clock-versus-furnace distinction — constitutional delay is a late but intact clock, permanent CHH is a defective clock, and primary gonadal failure is a clock with no furnace. Fourth, the induction principle — gradual sex-steroid escalation over 18 to 24 months to mimic normal puberty. [1]

The timing and the triad

This 14-year-old boy meets the definition: his testes are three millilitres, below the four-millilitre threshold for pubertal onset. The triad of short stature on the third centile with a mid-parental target on the fortieth, a bone age lagging by two and a half years, and both parents with a history of late puberty points to constitutional delay of growth and puberty — the commonest cause in boys, roughly 60 percent of referrals. His growth velocity is normal, which is reassuring: a falling-off velocity would force me to look beyond constitutional delay. [1]

The gonadotrophin split and the CDGP-versus-CHH problem

The single most discriminating test is the gonadotrophin level. Low or inappropriately normal FSH and LH with a low testosterone confirm a central cause, which is where this boy sits. The harder question is whether his central cause is temporary (CDGP) or permanent (CHH). The features that push toward CHH are anosmia (Kallmann syndrome), a history of micropenis or cryptorchidism at birth reflecting deficient neonatal minipuberty, a standing height that is normal-to-tall rather than short-for-age throughout childhood, and a family history of anosmia or infertility rather than just late puberty. This boy has none of those — his stature is short-for-age, his smell is intact, his neonatal history is unremarkable, and his family history is of late puberty — so constitutional delay is the working diagnosis, with a planned period of watchful waiting to confirm spontaneous progression. [1] [6]

The role of short-course testosterone

If the psychological burden is significant — and for a 14-year-old boy who is the shortest and least mature in his class, it often is — a short course of intramuscular testosterone (50 to 100 milligrams monthly for three to six months) serves two purposes. It induces the early changes of puberty and a growth spurt that relieves the distress, and it is a diagnostic trial: constitutional delay will show a pubertal response that continues after the course stops, whereas CHH will not progress independently. The Stancampiano structured approach emphasises that this is given at a dose and duration that does not advance bone age excessively or compromise final height. [12]

Branch 1: the high-gonadotrophin boy

The second case — a 15-year-old with tall stature, small firm testes, gynaecomastia, and markedly elevated FSH and LH with a low testosterone — is hypergonadotropic hypogonadism, and the phenotype is Klinefelter syndrome (47,XXY), the commonest genetic cause of primary gonadal failure at roughly one in 600 male births. The confirmatory test is a karyotype. The supernumerary X causes dysgenesis of the seminiferous tubules, low testosterone, and loss of feedback with rising gonadotrophins. The associated features are learning and behavioural vulnerabilities, metabolic and cardiovascular risk, osteoporosis, and infertility. [7] [1]

Branch 2: pubertal induction and fertility

Pubertal induction in Klinefelter uses escalating testosterone over 18 to 24 months — low-dose intramuscular or transdermal testosterone started at a fraction of the adult dose and increased gradually, per the Endo-ERN guideline. Rapid escalation is harmful because it advances bone age and compromises final height and because it outpaces psychosocial maturation. Fertility is impaired but micro-dissection testicular sperm extraction can recover sperm in many men, so early semen analysis and cryopreservation counselling are part of the long-term plan. Induction is followed by lifelong replacement and transition to adult endocrine care. [9] [7]

References

  1. [1]Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med, 2012.PMID 22296078
  2. [6]Stamou MI, Georgopoulos NA. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metabolism, 2018.PMID 29108899
  3. [7]Groth KA, Skakkebæk A, Høst C, Gravholt CH, Bojesen A. Clinical review: Klinefelter syndrome--a clinical update. J Clin Endocrinol Metab, 2013.PMID 23118429
  4. [9]Nordenström A, Ahmed SF, van den Akker E, et al. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline. Eur J Endocrinol, 2022.PMID 35353710
  5. [12]Stancampiano MR, Lucas-Herald AK, Russo G, Ahmed SF. Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach. Horm Res Paediatr, 2019.PMID 31851967